Novonix Ebit from 2010 to 2024

NVX Stock  USD 1.94  0.04  2.02%   
Novonix EBIT yearly trend continues to be fairly stable with very little volatility. EBIT is likely to outpace its year average in 2024. During the period from 2010 to 2024, Novonix EBIT regression line of annual values had r-squared of  0.82 and arithmetic mean of (13,684,539). View All Fundamentals
 
EBIT  
First Reported
2015-09-30
Previous Quarter
-17.2 M
Current Value
-27.2 M
Quarterly Volatility
7.8 M
 
Yuan Drop
 
Covid
Check Novonix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novonix's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5 M, Interest Expense of 3 M or Selling General Administrative of 16.1 M, as well as many indicators such as Price To Sales Ratio of 19.13, Dividend Yield of 0.0167 or PTB Ratio of 1.4. Novonix financial statements analysis is a perfect complement when working with Novonix Valuation or Volatility modules.
  
Check out the analysis of Novonix Correlation against competitors.

Latest Novonix's Ebit Growth Pattern

Below is the plot of the Ebit of Novonix Ltd ADR over the last few years. It is Novonix's EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novonix's overall financial position and show how it may be relating to other accounts over time.
Ebit10 Years Trend
Slightly volatile
   Ebit   
       Timeline  

Novonix Ebit Regression Statistics

Arithmetic Mean(13,684,539)
Geometric Mean8,558,077
Coefficient Of Variation(139.47)
Mean Deviation15,546,437
Median(7,160,392)
Standard Deviation19,086,303
Sample Variance364.3T
Range50.9M
R-Value(0.91)
Mean Square Error70.2T
R-Squared0.82
Slope(3,866,966)
Total Sum of Squares5100T

Novonix Ebit History

2024-41.4 M
2023-43.6 M
2022-36.8 M
2021-47.5 M
2020-13.7 M
2019-11.1 M
2018-15.7 M

Other Fundumenentals of Novonix Ltd ADR

About Novonix Financial Statements

Novonix investors use historical fundamental indicators, such as Novonix's Ebit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Novonix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBIT-43.6 M-41.4 M
EBITDA-38.9 M-36.9 M
Ebt Per Ebit 1.02  1.33 
Ebit Per Revenue(3.75)(3.93)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Novonix Stock Analysis

When running Novonix's price analysis, check to measure Novonix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novonix is operating at the current time. Most of Novonix's value examination focuses on studying past and present price action to predict the probability of Novonix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novonix's price. Additionally, you may evaluate how the addition of Novonix to your portfolios can decrease your overall portfolio volatility.